Vaccine Development and Clinical Trials

Why does it take so long to develop vaccines? The COVID-19 pandemic has raised questions about the logistics in creating a new vaccine. Some may be frustrated with the slow pace of research and approval. In this seminar we learned about the process of vaccine development, whether we can speed up the process and get vaccines out quicker, and if there are corners that we can cut in the time of pandemic.

Thanks to our fantastic panel experts:

Bill Hearl, CEO, Immunomic Therapeutics
B. Kim Lee Sim , President and Chief Scientific Officer, Protein Potential and Executive VP, Sanaria Inc.
Sharon Tennant, Associate Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine